Penetration and haptenation of p-phenylenediamine

Contact Dermatitis

Volumn 68, Issue 4, 2013, Pages 193-207

  Pot, Laura M ^a   Scheitza, Simone M ^b   Coenraads, Pieter Jan ^a   Blömeke, Brunhilde ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF TRIER   (Germany)

Author keywords

haptenation; p phenylenediamine; penetration; protein binding; sensitization

Indexed keywords

2,3 BUTANEDIONE; ACYLTRANSFERASE; AMINO ACID; CYSTEINE; HAIR DYE; HAPTEN; LYSINE; PHENYLENEDIAMINE;

ACETYLATION; AUTOOXIDATION; CONTACT SENSITIZATION; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; EPIDERMIS; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATION; PROTEIN BINDING; PROTEIN TARGETING; REVIEW; SKIN PENETRATION; SKIN SENSITIZATION; URINARY EXCRETION;

ACETYLATION; ADMINISTRATION, TOPICAL; ANIMALS; COLORING AGENTS; DERMATITIS, ALLERGIC CONTACT; HAIR DYES; HUMANS; PHENYLENEDIAMINES; SKIN ABSORPTION;

EID: 84875349327     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12032     Document Type: Review

References (95)

1. Council Directive of 27 July on the approximation of the laws of Member States relating to cosmetic products (76/768/EEC). Off J Eur Union 1976: L262: 169-200.
2. U. S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Cosmetics and Colors Fact Sheet April 18, 2001, Updated September 18, 2006. Available at: http://www.gpo.gov/fdsys/pkg/USCODE-2010- title21/pdf/USCODE-2010-title21-chap9-subchapVI-sec361.pdf (last accessed 23 April 2012).
3. Thyssen J P, Andersen K E, Bruze M et al., p-Phenylenediamine sensitization is more prevalent in central and southern European patch test centres than in Scandinavian: results from a multicentre study. Contact Dermatitis 2009: 60: 314-319.
4. Uter W, Lessmann H, Geier J, Schnuch A., Contact allergy to hairdressing allergens in female hairdressers and clients -current data from the IVDK, 2003-2006. J Dtsch Dermatol Ges 2007: 5: 993-1001.
5. Rustemeyer T, Van Hoogstraten I M W, von Blomberg B M E, Gibs S, Scheper R J., Mechanisms of irritant and allergic contact dermatitis. In: Contact Dermatitis, 5th edition, Johansen J D, Frosch P J, Lepoittevin J-P, (eds): Berlin, Heidelberg, Springer-Verlag, 2011: pp. 43-90.
6. Bos J D, Meinardi M M., The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000: 9: 165-169.
7. Proksch E, Brandner J M, Jensen J M., The skin: an indispensable barrier. Exp Dermatol 2008: 17: 1063-1072.
8. Bashir S J, Chew A L, Anigbogu A, Dreher F, Maibach H I., Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol 2001: 7: 40-48.
9. Berard F, Marty J P, Nicolas J F., Allergen penetration through the skin. Eur J Dermatol 2003: 13: 324-330.
10. Smith Pease C K, White I R, Basketter D A., Skin as a route of exposure to protein allergens. Clin Exp Dermatol 2002: 27: 296-300.
11. McCarley K D, Bunge A L., Pharmacokinetic models of dermal absorption. J Pharm Sci 2001: 90: 1699-1719.
12. Fernandez C, Nielloud F, Fortune R, Vian L, Marti-Mestres G., Benzophenone-3: rapid prediction and evaluation using non-invasive methods of in vivo human penetration. J Pharm Biomed Anal 2002: 28: 57-63.
13. Pouillot A, Dayan N, Polla A S, Polla L L, Polla B S., The stratum corneum: a double paradox. J Cosmet Dermatol 2008: 7: 143-148.
14. Schaefer H, Lademann J., The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 2001: 14 (Suppl. 1): 23-27.
15. Chourasia R, Jain S K., Drug targeting through pilosebaceous route. Curr Drug Targets 2009: 10: 950-967.
16. Lee A J, King J R, Rogers T G., A multiple-pathway model for the diffusion of drugs in skin. IMA J Math Appl Med Biol 1996: 13: 127-150.
17. Albery W J, Hadgraft J., Percutaneous absorption: in vivo experiments. J Pharm Pharmacol 1979: 31: 140-147.
18. Nemanic M K, Elias P M., In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem 1980: 28: 573-578.
19. Potts R O, Francoeur M L., The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991: 96: 495-499.
20. Bouwstra J A, van den Bergh B A, Suhonen M., Topical application of drugs: mechanisms involved in chemical enhancement. J Recept Signal Transduct Res 2001: 21: 259-286.
21. Madison K C, Swartzendruber D C, Wertz P W, Downing D T., Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987: 88: 714-718.
22. Menon G K, Elias P M., Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 1997: 10: 235-246.
23. Hadgraft J., Skin deep. Eur J Pharm Biopharm 2004: 58: 291-299.
24. Blume-Peytavi U, Massoudy L, Patzelt A, Lademann J, Dietz E, Rasulev U, Garcia Bartels N., Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur J Pharm Biopharm 2010: 76: 450-453.
25. Smith H R, Basketter D A, McFadden J P., Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 2002: 27: 138-146.
26. Bonneville M, Chavagnac C, Vocanson M et al., Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007: 127: 1430-1435.
27. Segre J A., Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006: 116: 1150-1158.
28. Yamamoto A, Serizawa S, Ito M, Sato Y., Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991: 283: 219-223.
29. Thyssen J P, Johansen J D, Linneberg A et al., The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010: 162: 1278-1285.
30. van Ravenzwaay B, Leibold E., A comparison between in vitro rat and human and in vivo rat skin absorption studies. Hum Exp Toxicol 2004: 23: 421-430.
31. Hueber-Becker F, Nohynek G J, Meuling W J, Benech-Kieffer F, Toutain H., Human systemic exposure to a [14C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. Food Chem Toxicol 2004: 42: 1227-1236.
32. Sznitowska M, Janicki S, Baczek A., Studies on the effect of pH on the lipoidal route of penetration across stratum corneum. J Controlled Release 2001: 76: 327-335.
33. Matoltsy A G, Downes A M, Sweeney T M., Studies of the epidermal water barrier. II. Investigation of the chemical nature of the water barrier. J Invest Dermatol 1968: 50: 19-26.
34. Kawakubo Y, Merk H F, Masaoudi T A, Sieben S, Blomeke B., N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J Pharmacol Exp Ther 2000: 292: 150-155.
35. Goetz N, Lasserre P, Bore P, Kalopissis G., Percutaneous absorption of p-phenylene diamine during an actual hair dyeing procedure. Int J Cosmet Sci 1988: 10: 63-73.
36. Nohynek G J, Skare J A, Meuling W J, Hein D W, De Bie A T, Toutain H., Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye. Food Chem Toxicol 2004: 42: 1885-1891.
37. Wolfram L J, Maibach H I., Percutaneous penetration of hair dyes. Arch Dermatol Res 1985: 277: 235-241.
38. Dressler W E, Appelqvist T., Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine. Food Chem Toxicol 2006: 44: 371-379.
39. Hu T, Bailey R E, Morrall S W, Aardema M J, Stanley L A, Skare J A., Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model. Toxicol Lett 2009: 188: 119-129.
40. Goebel C, Coenraads P J, Rothe H, Kunze G, Kock M, Schlatter H, Gerberick G F, Blomeke B., Elicitation of the immune response to p-phenylenediamine in allergic patients: the role of dose and exposure time. Br J Dermatol 2010: 163: 1205-1211.
41. Steiling W, Kreutz J, Hofer H., Percutaneous penetration/dermal absorption of hair dyes in vitro. Toxicol In Vitro 2001: 15: 565-570.
42. Kiese M, Rauscher E., The absorption of p-toluenediamine through human skin in hair dyeing. Toxicol Appl Pharmacol 1968: 13: 325-331.
43. Hruby R., The absorption of p-toluenediamine by the skin of rats and dogs. Food Cosmet Toxicol 1977: 15: 595-599.
44. European Commission, Scientific Committee on Consumer Products. Opinion on Toluene-2,5-diamine, 2007. Available at: http://ec.europa.eu/health/ph-risk/ committees/04-sccp/docs/sccp-o-108.pdf (last accessed 23 April 2012).
45. European Commission, Scientific Committee on Consumer Safety. Opinion on p-Phenylenediamine, 2012. Available at: http://ec.europa.eu/health/scientific- committees/consumer-safety/docs/sccs-o-094.pdf (last accessed 16 October 2012).
46. White J M, Basketter D A, Pease C K, Sanders D A, McFadden J P., Intermittent exposure to low-concentration paraphenylenediamine can be equivalent to single, higher-dose exposure. Contact Dermatitis 2007: 56: 262-265.
47. Jansen L H, Hojyo-Tomoko M T, Kligman A M., Improved fluorescence staining technique for estimating turnover of the human stratum corneum. Br J Dermatol 1974: 90: 9-12.
48. Platzek T., Risk from exposure to arylamines from consumer products and hair dyes. Front Biosci (Elite Ed) 2010: 2: 1169-1183.
49. Van Gele M, Geusens B, Brochez L, Speeckaert R, Lambert J., Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations. Expert Opin Drug Deliv 2011: 8: 705-720.
50. Thakoersing V S, Gooris G S, Mulder A, Rietveld M, El Ghalbzouri A, Bouwstra J A., Unraveling barrier properties of three different in-house human skin equivalents. Tissue Eng Part C Methods 2012: 18: 1-11.
51. Bonifas J, Scheitza S, Clemens J, Blomeke B., Characterization of N-acetyltransferase 1 activity in human keratinocytes and modulation by para-phenylenediamine. J Pharmacol Exp Ther 2010: 334: 318-326.
52. Brancaccio R R, Brown L H, Chang Y T, Fogelman J P, Mafong E A, Cohen D E., Identification and quantification of para-phenylenediamine in a temporary black henna tattoo. Am J Contact Dermat 2002: 13: 15-18.
53. Kang I J, Lee M H., Quantification of para-phenylenediamine and heavy metals in henna dye. Contact Dermatitis 2006: 55: 26-29.
54. Marzulli F N, Maibach H I., The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. Food Cosmet Toxicol 1974: 12: 219-227.
55. Thyssen J P, White J M, European Society of Contact Dermatitis. Epidemiological data on consumer allergy to p-phenylenediamine. Contact Dermatitis 2008: 59: 327-343.
56. Roberts D W, Aptula A O., Determinants of skin sensitisation potential. J Appl Toxicol 2008: 28: 377-387.
57. Roberts D W, Natsch A., High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles. Chem Res Toxicol 2009: 22: 592-603.
58. Jowsey I R, Basketter D A, Westmoreland C, Kimber I., A future approach to measuring relative skin sensitising potency: a proposal. J Appl Toxicol 2006: 26: 341-350.
59. Chipinda I, Hettick J M, Siegel P D., Haptenation: chemical reactivity and protein binding. J Allergy (Cairo) 2011: 2011; doi:10.1155/2011/839682.
60. Kimber I, Dearman R J, Basketter D A, Ryan C A, Gerberick G F., The local lymph node assay: past, present and future. Contact Dermatitis 2002: 47: 315-328.
61. Gerberick G F, Vassallo J D, Bailey R E, Chaney J G, Morrall S W, Lepoittevin J P., Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci 2004: 81: 332-343.
62. Gerberick G F, Vassallo J D, Foertsch L M, Price B B, Chaney J G, Lepoittevin J P., Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol Sci 2007: 97: 417-427.
63. Landsteiner K, Jacobs J., Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935: 61: 643-656.
64. Dupuis G, Benezra C., Allergic Contact Dermatitis to Simple Chemicals. A Molecular Approach: New York, Marcel Dekker, 1982.
65. Lepoittevin J P., Metabolism versus chemical transformation or pro- versus prehaptens? Contact Dermatitis 2006: 54: 73-74.
66. Schmidt R J., Free radicals and the antioxidant hypothesis of prohapten activation. Contact Dermatitis 2007: 57: 65-67.
67. Aptula A O, Roberts D W, Pease C K., Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles. Contact Dermatitis 2007: 56: 54-56.
68. Gerberick G F, Troutman J A, Foertsch L M, Vassallo J D, Quijano M, Dobson R L, Goebel C, Lepoittevin J P., Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol Sci 2009: 112: 164-174.
69. Ahlfors S R, Sterner O, Hansson C., Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts. Skin Pharmacol Appl Skin Physiol 2003: 16: 59-68.
70. Aleksic M, Pease C K, Basketter D A, Panico M, Morris H R, Dell A., Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicol In Vitro 2007: 21: 723-733.
71. Aleksic M, Thain E, Roger D, Saib O, Davies M, Li J, Aptula A, Zazzeroni R., Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment. Toxicol Sci 2009: 108: 401-411.
72. Eilstein J, Gimenez-Arnau E, Duche D, Rousset F, Lepoittevin J P., Synthesis and reactivity toward nucleophilic amino acids of 2,5-[13C]-dimethyl- p-benzoquinonediimine. Chem Res Toxicol 2006: 19: 1248-1256.
73. Eilstein J, Gimenez-Arnau E, Duche D, Rousset F, Lepoittevin J P., Mechanistic studies on the lysine-induced N-formylation of 2,5-dimethyl-p- benzoquinonediimine. Chem Res Toxicol 2007: 20: 1155-1161.
74. Eilstein J, Gimenez-Arnau E, Duche D, Cavusoglu N, Hussler G, Rousset F, Lepoittevin J P., Sensitization to p-amino aromatic compounds: study of the covalent binding of 2,5-dimethyl-p-benzoquinonediimine to a model peptide by electrospray ionization tandem mass spectrometry. Bioorg Med Chem 2008: 16: 5482-5489.
75. Jenkinson C, Jenkins R E, Maggs J L, Kitteringham N R, Aleksic M, Park B K, Naisbitt D J., A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine. Chem Res Toxicol 2009: 22: 1172-1180.
76. Natsch A, Gfeller H., LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol Sci 2008: 106: 464-478.
77. Divkovic M, Pease C K, Gerberick G F, Basketter D A., Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 2005: 53: 189-200.
78. Gerberick F, Aleksic M, Basketter D et al., Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim 2008: 36: 215-242.
79. Smith C K, Hotchkiss S A M., Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms: London and New York, Taylor and Francis, 2001: 310 pp.
80. Meschkat E, Barratt M D, Lepoittevin J., Studies of the chemical selectivity of hapten, reactivity, and skin sensitization potency. 1. Synthesis and studies on the reactivity toward model nucleophiles of the (13)C-labeled skin sensitizers hex-1-ene- and hexane-1,3-sultones. Chem Res Toxicol 2001: 14: 110-117.
81. Alvarez-Sanchez R, Basketter D, Pease C, Lepoittevin J P., Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI). Chem Res Toxicol 2003: 16: 627-636.
82. Alvarez-Sanchez R, Divkovic M, Basketter D, Pease C, Panico M, Dell A, Morris H, Lepoittevin J P., Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry. Chem Res Toxicol 2004: 17: 1280-1288.
83. Aeby P, Sieber T, Beck H, Gerberick G F, Goebel C., Skin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J Invest Dermatol 2009: 129: 99-109.
84. Blomeke B, Pietzsch T, Merk H F., Elicitation response characteristics to mono- and to N,N′-diacetyl-para-phenylenediamine. Contact Dermatitis 2008: 58: 355-358.
85. Butcher N J, Ilett K F, Minchin R F., Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 2000: 57: 468-473.
86. White J M, Kullavanijaya P, Duangdeeden I, Zazzeroni R, Gilmour N J, Basketter D A, McFadden J P., p-Phenylenediamine allergy: the role of Bandrowski's base. Clin Exp Allergy 2006: 36: 1289-1293.
87. Hennen J, Aeby P, Goebel C, Schettgen T, Oberli A, Kalmes M, Blomeke B., Cross talk between keratinocytes and dendritic cells: impact on the prediction of sensitization. Toxicol Sci 2011: 123: 501-510.
88. Krasteva M, Nicolas J F, Chabeau G, Garrigue J L, Bour H, Thivolet J, Schmitt D., Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine. Int Arch Allergy Immunol 1993: 102: 200-204.
89. European Commission, Scientific Committee on Consumer Products. Opinion on exposure to reactants and reaction products of oxidative hair dye formulations, 2005. Available at: http://ec.europa.eu/health/ph-risk/committees/ 04-sccp/docs/sccp-o-032.pdf (last accessed 23 April 2012).
90. Aleksic M, Thain E, Roger D, Saib O, Davies M, Li J, Aptula A, Zazzeroni R., Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment. Supplementary data. Supplementary Table S1. Toxicol Sci 2009: 108: 401-411.
91. Aptula A O, Enoch S J, Roberts D W., Chemical mechanisms for skin sensitization by aromatic compounds with hydroxy and amino groups. Chem Res Toxicol 2009: 22: 1541-1547.
92. Natsch A, Emter R, Ellis G., Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol Sci 2009: 107: 106-121.
93. Troutman J A, Foertsch L M, Kern P S et al., The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol Sci 2011: 122: 422-436.
94. Jenkinson C, Jenkins R E, Aleksic M, Pirmohamed M, Naisbitt D J, Park B K., Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein. J Invest Dermatol 2010: 130: 732-742.
95. Krasteva M, Bons B, Ryan C, Gerberick G F., Consumer allergy to oxidative hair coloring products: epidemiologic data in the literature. Dermatitis 2009: 20: 123-141.